A pro-regenerative cell discovered by researchers at Ohio State and the University of Michigan could open the door to potentially groundbreaking immunotherapeutic treatments for diseases such as ALS and multiple sclerosis.
If you are not happy with the results below please do another search
50 search results for:
UW Health University Hospital in Madison, Wisconsin has been rushing to convert available space into units for Covid-19 patients, as the state’s medical facilities struggle to keep pace with a surge in new infections.
A new study suggests that some patients could see a decline in cognition that is equivalent to the brain aging approximately 10 years.
The U.S. Food and Drug Administration approved Kala Pharmaceuticals’ Eysuvis for the short-term treatment of dry eye disease.
Swiss pharma giant Novartis AG is harnessing the power of Zurich-based Molecular Partners AG’s DARPin platform to develop two therapeutic candidates that could both be used to prevent and treat Covid-19 infection.
Pfizer indicated that the company’s Phase III clinical trial of 44,000 volunteers with partner BioNTech needed less than 2,000 people to be fully enrolled.
The U.S. government will pay as much as $1.19 billion to Eli Lilly to secure nearly 1 million doses of the company’s experimental Covid-19 antibody treatment, a drug similar to a treatment that U.S. President Donald Trump received.
Walmart Inc., Walgreens Boots Alliance Inc., CVS Health Corp. and Rite Aid Corp. told Reuters demand for flu shots at their U.S. pharmacies is up sharply – in some cases double from 2019 – as people try to protect themselves from influenza in the midst of a worsening Covid-19 pandemic.
French drugmaker Sanofi and Britain’s GlaxoSmithKline will supply 200 million doses of their Covid-19 candidate vaccine to a global inoculation scheme backed by the World Health Organization.
Integrated creative network Ogilvy announced that Kate Cronin was appointed Chief Executive Officer of Ogilvy Health.